How to Prove Biosimilarity Using LC-MS/MS: Regulatory Expectations and Analytical Workflow
Introduction: Why LC-MS/MS Is Central to Proving Biosimilarity Using LC-MS To Prove Biosimilarity Using LC-MS, companies must meet strict scientific […]
Reverse Engineering Risperidone PLGA Microspheres: Controlling Lag Phase Through Polymer Characterization
Introduction: Reverse Engineering Risperidone PLGA Microspheres is a critical approach in modern pharmaceutical development, particularly for long-acting injectable formulations. By
Biosimilar Characterization Using Mass Spectrometry: Complete Analytical Strategy for Structural Comparability
The Strategic Imperative of Biosimilar Characterization Using Mass Spectrometry Biosimilar Characterization Using Mass Spectrometry is a critical scientific approach used
Dulaglutide Sameness Study: Peptide Sequencing, Peptide Mapping, Impurity Profiling by HRMS/LCMS and 1D-2D NMR for ANDA Success
Summary: Dulaglutide Sameness Study is a comprehensive analytical comparison demonstrating that a proposed generic dulaglutide product is structurally and chemically
Case Study: Exenatide PLGA Microsphere Characterization – Overcoming Peptide–Polymer Interaction Challenges
Introduction: Exenatide PLGA Microsphere Characterization plays a pivotal role in the development of long-acting injectable formulations, particularly for GLP-1 analogs
Nitrosamine Testing for Rifabutin API and Finished Products
Introduction: Nitrosamine Testing for Rifabutin is an essential safety and regulatory process used to detect and measure harmful impurities, including
Nitrosamine Testing for Rifabutin API and Finished Products Read More »
Nitrosamine Testing for Rifapentine API and Finished Products
Introduction: Why Nitrosamine Testing for Rifapentine Needs a Specialized Approach Nitrosamine Testing for Rifapentine is not a simple lab task.
Nitrosamine Testing for Rifapentine API and Finished Products Read More »
How to Characterize Active Ingredients in Finished Dosage Forms for ANDA
Introduction: Active Ingredient Characterization for ANDA submission is a fundamental requirement to establish that the generic product matches the reference
How to Characterize Active Ingredients in Finished Dosage Forms for ANDA Read More »
Retatrutide Sameness Study: Peptide Sequencing, Peptide Mapping, Impurity Profiling by HRMS/LCMS and 1D-2D NMR for ANDA Success
Summary: 1. Introduction A Retatrutide Sameness Study is the mandatory analytical validation required to prove that a generic synthetic peptide
Regulatory Requirements for Long Acting Injectable Formulation Development (FDA & Health Canada)
The Regulatory Requirements for Long Acting Injectable Development are complex and demand a clear link between formulation design, manufacturing quality,